Click here for Prescribing information and Adverse event reporting, further details on adverse event reporting can be found at the bottom of the page

Imprint

Published by:

Bayer Public Limited Company

Registered Office:

Bayer Public Limited Company
400 South Oak Way
Green Park
Reading
Berkshire
United Kingdom
RG2 6AD

Tel: +44 (0) 118 206 3000
Fax: +44 (0) 118 206 3513
e mail: communications.UKIreland@bayer.com

Bayer is registered in England No. 935048

VAT No. GB 641 958 611
© Copyright Bayer plc 2021

This website is intended for a UK audience.

PP-VER-GB-0033 | November 2022

Reporting adverse events and quality complaints

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 0118 206 3500 or Email: pvuk@bayer.com

Further information is available on the "contact" tab at www.bayer.co.uk.

This website contains information on Verquvo^® (vericiguat) which is based on the Summary of Product Characteristics (SmPC). Intended for UK audience only.

PP-VER-GB-0028 November 2022